Coriolis Pharma is a globally active contract research and development organization (CRDO), specializing in formulation development for biopharmaceuticals, including cell and gene therapies and vaccines. With laboratories in Germany and North Carolina, we offer services under both R&D and GMP conditions.

Focusing on liquid and lyophilized drug products, our expert scientists design and implement platform and customized services to accelerate and derisk your development program—right from the start and throughout the entire product lifecycle.

As a science-driven and independent partner, we tailor our approach to your specific molecule and development phase, always keeping your end goal in mind.